Ursodeoxycholic acid for stomach precancer reversal
Treatments studied
Part of Digestive system clinical trials.
This trial tests if ursodeoxycholic acid can reverse intestinal metaplasia (a precancerous stomach condition) in patients who have no H. pylori infection. The goal is to see if this medication can help lower the risk of stomach cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 75 years
- Diagnosed with a moderate to advanced stage of stomach precancer (OLGIM stage II–IV) in the last 3 months
- No current H. pylori infection (must have been treated if previously infected)
- Not regularly taking NSAID pain relievers or statins
- No prior stomach surgery or cancer diagnosis
- No severe heart, kidney, or liver disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether berberine, a natural plant compound, can help reverse precancerous changes in the stomach lining. If you have a certain type of stomach cell change (called gastric intestinal metaplasia) and do not have an H. pylori infection, this study might be an option.
This trial tests whether a treatment can reverse stomach lining changes called GIM that increase cancer risk. It's for people who have had a past H. pylori infection but no current stomach cancer, and whose GIM has certain high-risk features.
This study tests if Weifuchun tablets can reverse precancerous changes called gastric intestinal metaplasia. If you have this condition and no H. pylori infection, you may qualify.
This study collects health information from people at different stages of stomach cancer risk, including those with precancerous changes, healthy individuals, and those with early stomach cancer. The goal is to better understand and prevent stomach cancer.
This trial compares a “dual eradication therapy” (to get rid of H. pylori in the stomach) versus usual acid-reducing pills (PPIs) to lower the risk of gastrointestinal bleeding in people with recent heart artery disease treated with a stent. It may help by reducing stomach infection-related bleeding while you continue needed heart medicines.
This trial tests whether a safe, older drug (pyrvinium) can reverse abnormal changes in the stomach lining that may lead to cancer. It might help people who have precancerous cells in their stomach to prevent them from becoming cancer.
Hear when a new Gastric Intestinal Metaplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.